Login
← Go Back
Natco Pharma
NATCOPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: V C Nannapaneni · MD: V C Nannapaneni · Listing date: Dec. 27, 1995 · Employees: 5046 · Hyderabad · http://www.natcopharma.co.in
Stock Price vs Company Growth
1d
2.0%
1w
0.1%
1m
0.8%
3m
15.9%
6m
26.4%
1y
1.8%
5y
1.1%
10y
3.9%
all
19.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 801 2.0%
779
953
Company Overview
Sales
3,485 Cr
Growth: -8.9%
Profit after Tax
1,144 Cr
Growth: -19.3%
Mid Cap
15,708 Cr
P/E: 12.5x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 3,485
Growth -8.9%
EBITDA 30.2%
P/S 4.5x
Dividend 0.6%
P/E 12.5x
Book Value ₹ 481
PEG Ratio -1.4x
ROE 12.7%
P/B 1.6x
Shareholding Pattern
Institutions
Qualified Institutional Buyers
6.25 %
Mirae Asset Emerging Bluechip Fund
4.06 %
Life Insurance Corporation Of India
2.46 %
Plenty Private Equity Fii I Limited
1.74 %
Nomura Singapore Limited
1.69 %
Promoters
V C Nannapaneni
12.39 %
Time Cap Pharma Labs Limited
9.42 %
Venkata Satya Swathi Kantamani
8.77 %
Natsoft Information Systems Pvt Ltd
8.65 %
Venkaiah Chowdary Nannapaneni Huf
2.98 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in the business of pharmaceuticals and agricultural chemicals which comprises research and development, manufacturing and selling of bulk drugs, finished dosage formulations. The Company has manufacturing facilities in India which caters to both domestic and international markets including regulated markets like United States of America and Europe.
Belongs to (36 Indices) view more
Investors (170)
em.resur...
marshall...
ndl.infr...
Followers (40)
nitin2
keerthi
deepak